A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
OBJECTIVE
Lower urinary tract symptoms (LUTS) are common in both men and women, and are among the most prevalent patient complaints heard by primary care physicians (PCPs). This article aims to provide PCPs with a logical algorithm for the assessment and initiation of treatment for LUTS in the male patient.


RESULTS
Management of LUTS involves a focused history and physical, as well as the assessment of bother. In patients for whom treatment is warranted, a series of decisions regarding therapy should be considered. Male patients commonly suffer from storage and/or voiding symptoms. Treatment of male LUTS is commonly begun with agents that are aimed at remedying the outlet symptoms of benign prostatic hyperplasia (BPH). When this intervention is ineffective or when refractory symptoms persist, consideration should be given to treating the storage symptoms characteristic of overactive bladder (OAB).


CONCLUSIONS
This article is intended to provide the PCP with a logical guide to the treatment of male LUTS. Benign prostatic hyperplasia and OAB predominate among the causes of these symptoms, and the PCP should be comfortable treating each. Recent data detailing the safety of the use of these treatments in the male patient are reviewed and incorporated into the algorithm.


CONCLUSIONS
Primary care physicians are in a unique position to successfully identify and treat male patients with LUTS. With this paper, they now have a tool to approach treatment logically and practically.
Rosenberg
M T
MT
Mid-Michigan Health Centers, Department of Family Medicine, Foote Health System, Jackson, MI, USA. matttoren@yahoo.com
Staskin
D R
DR
Kaplan
S A
SA
MacDiarmid
S A
SA
Newman
D K
DK
Ohl
D A
DA
D000368:Aged; D000465:Algorithms; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011320:Primary Health Care; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy; D053201:Urinary Bladder, Overactive / Q000150:complications; D014555:Urination Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology